NCT06610422Not yet recruiting
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients With Lupus Nephritis in Assiut University Hospital
Source: ClinicalTrials.gov · Last updated 24 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
1. Frequency of peripheral neuropathy associated with lupus nephritis 2. Sensitivity and specificity of some biomarkers used in diagnosis and follow up of SLE with lupus nephritis and peripheral neuropathy
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 159 (estimated)
- First submitted
- 20 Sept 2024
- Start date
- Jan 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Assiut University
- Diseases
- Lupus (SLE)
- NCT number
- NCT06610422
What you commit to
- Study type: Observational
- Planned participants: 159
- From Jan 2025 to the primary completion date, Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1.history of viral hepatitis B or C 2.A history of malignancy (excluding basal cell carcinoma) 3.pulse therapy 4.chronic kidney disease (CKD) stage 5 or hemodialysis 5.SLE not associated with renal affect
Who the study is looking for
- 1\. Female patients
- 2\. Age ≥ 18 years
- 3\. Patients diagnosed as SLE and lupus nephritis as clinical, laboratory investigations and renal biopsy for indicated cases 4. Anti phospholipid antibodies (IgG \& IgM) 5.Associated vasculitis ( cANCA \& pANCA ) 6.Active - inactive classes of SLE 7.CKD stage I \& IV not on dialysis
Age in the registry: 18 years to 80 years · Sex: Female
This page is information, not medical advice. Discuss any trial with your doctor.